Home | About | Journals | Submit | Contact Us | Français |

**|**HHS Author Manuscripts**|**PMC3160274

Formats

Article sections

Authors

Related links

Epidemiology. Author manuscript; available in PMC 2012 September 1.

Published in final edited form as:

PMCID: PMC3160274

NIHMSID: NIHMS309502

Biostatistics Branch, National Institute of Environmental Health Sciences

Correspondence: P. Saha Chaudhuri, Biostatistics Branch, National Institute of Environmental Health Sciences, P.O. Box 12233, Mail Drop A3-03, 111 T.W. Alexander Drive, Research Triangle Park, North Carolina 27709, Phone: 919-541-9954, Fax: 919-541-4311, sahap/at/niehs.nih.gov

The publisher's final edited version of this article is available at Epidemiology

See other articles in PMC that cite the published article.

Exposure assessment using biologic specimens is important for epidemiology but may become impracticable if assays are expensive, specimen volumes are marginally adequate, or analyte levels fall below the limit of detection. Pooled exposure assessment can provide an effective remedy for these problems in unmatched case-control studies. We extend pooled exposure strategies to handle specimens collected in a matched case-control study. We show that if a logistic model applies to individuals, then a logistic model also applies to an analysis using pooled exposures. Consequently, the individual-level odds ratio can be estimated while conserving both cost and specimen. We discuss appropriate pooling strategies for a single exposure, with adjustment for multiple, possibly continuous, covariates(confounders)and assessment of effect modification by a categorical variable. We assess the performance of the approach via simulations and conclude that pooled strategies can markedly improve efficiency for matched as well as unmatched case-control studies.

Exposure assessment in epidemiology, particularly for biomonitoring and surveillance, often involves measurement of multiple analytes from stored biologic specimens. Assay expense, however, sometimes constrains the number of subjects and/or chemicals examined. Studies may also suffer from inadequate specimen volumes and from analyte levels below the assay’s limit of detection(LOD). For example, out of 148 chemicals assessed in specimens collected in 1999–2002, the US Centers for Disease Control and Prevention (CDC) provided no summary measures (e.g. geometric means or percentiles)for 22% of the chemicals and only a limited summary for another 41%^{1}. As the author explained, “These estimates could not be reported … either because of an extremely low exposure level or an insufficient quantity of body fluid or tissue.”^{2}

Pooled exposure assessment can alleviate the three issues of assay expense, analyte levels below the LOD, and specimens with inadequate volumes. The idea is to partition individuals into disjoint pooling sets, combine small equal-volume aliquots from individuals in each pooling set, and then assay one pooled specimen per set instead of one per person. The exposure level of a pooled specimen is the arithmetic mean for the individuals in the pool. Pooling reduces both the number of assays and the specimen volume required from each subject. Thus, pooling depletes less of the biospecimen resource and enables inclusion of more people and more exposures within a given budget.

Specimen pooling was introduced during World War II for efficiently screening military inductees for syphilis^{3} and was later employed for other infectious diseases.^{4–6} Pooling was used to estimate the prevalence and incidence of HIV ^{7} while protecting the privacy of individuals, and to assess diagnostic accuracy of biomarkers.^{8} DNA pooling has been proposed for identification of susceptibility loci in large-scale association studies.^{9}

Another useful application of pooling is to estimate the relative odds associated with exposure based on a case-control study.^{10} After stratification on disease status(and possibly on covariates), individuals in each stratum are randomly partitioned into pooling sets before assay. With this strategy, the unit of analysis becomes the pooling set, rather than the individual participant. Nevertheless, a modified logistic regression allows valid and efficient maximum-likelihood estimation of the same odds ratio (OR) parameter for the exposure-disease relationship as would be estimated with exposure data from individuals. Pooling makes efficient use of a fixed assay budget with very little loss of statistical power. Moreover, if including an additional subject is relatively inexpensive compared with conducting an additional assay, then pooling can substantially improve power by enabling more people to be studied.

Matching,^{11–12} along with conditional logistic regression analysis, remains a widely used technique for controlling confounding and increasing efficiency in case-control studies. For assay-based exposure assessment, matched case-control studies face the same issues of expense, LOD and limited specimen volume as unmatched studies. In this article, we extend the pooled exposure strategies of Weinberg and Umbach^{10} for use with matched case-control studies. We show that, when pooling sets are appropriately constructed and exposure is measured in pooled specimens, conditional logistic regression using pooled measurements estimates the same exposure odds ratio parameter as with exposure measured in individuals. Such an approach would be useful for exploratory as well as confirmatory studies of exposure and disease assessment. For example, it could have been applied in studies of serum vitamin D concentration and breast cancer,^{13} the association between blood lead level and ADHD in children,^{14} or the association between PCB and non-Hodgkins lymphoma.^{15}

Let *U* denote the level of a continuous exposure of interest and *D* (1 for cases and 0 for controls)denote the disease status. To simplify the exposition we first consider a pair-matched case-control study. Assume the following logistic model for the *i*^{th} of N matched pairs:

(1)

where *β* denotes the log odds ratio (OR) associated with unit increase in exposure and α_{i} denotes the pair-specific baseline log odds of disease. Based on (1), the contribution of the *i*^{th} matched pair to the conditional logistic regression likelihood is:

(2)

and is free of *α _{i}*. This likelihood formulation extends readily to matched sets with more than one control per case.

A simple pooling strategy to allow estimation of *β* begins by randomly partitioning the matched pairs into sets of pairs. For simplicity, suppose that every set contains *g* pairs, where *N*=*gk*, for some integer *k*. For each such set of pairs, equal-volume aliquots from the *g* case specimens are combined to form a single pooled case specimen, and the corresponding *g* control specimens are pooled to form a single pooled control specimen. There are now *k* pairs of pools instead of *N* pairs of individuals. If we index the *g* specimens in a typical pooling set by *i*{1, 2, 3, … *g*}, the measured exposure in a pooled specimen is
where *U _{i}* denotes the level for the

Suppose that one of the following two events is observed: (1) *A*(*v*_{1}, *v*_{0}): the case set had *V*=*v*_{1} and the control set had *V*=*v*_{0}, or (2) *A*(*v*_{0}, *v*_{1}): the case set had *V*=*v*_{0} and the control set had *V*=*v*_{1}. Using the results from the Appendix, the contribution of each pair of pools to a conditional logistic likelihood is the conditional probability of *A*(*v*_{1}, *v*_{0}) given {*v*_{1}, *v*_{0}}, namely:

(3)

This likelihood contribution for a pair of pooled specimens, as seen by comparison with (2), is that of a standard conditional logistic model for a matched case-control study except that the exposure variables reflect the sum of individual exposures in the pools or *g* times the measured exposure in the pools. Consequently, maximum likelihood estimation with pooled specimens uses exactly the same procedure as with individual specimens; standard statistical packages estimate both the log OR and its standard error(SE)by treating g times the measured exposure in a pooled specimen as though it were an individual-level exposure. Because we multiplied the measured exposure by *g*, there is no explicit dependence on *g*. Hence, the same general model holds when the pooling sets of pairs contain different numbers of pairs.

Let *W* represent a confounder that can vary across individuals within a matching stratum. We assume the usual logistic model for the *i*^{th} stratum:

Because pooling sets are formed without considering the values of the confounder, confounders enter the model for pooling sets in the same way as exposures do, as the sum of the individual contributions within the set. Accordingly, let
be a summed confounder. Its value might be derived from another assay of the pooled specimen itself or by summing values recorded for the individuals who contributed to the pool. Continuous covariates need not be categorized, but categorical covariates should be summed as separate dummy variables. Let *z*_{1} and *z*_{0} be values of the summed confounder for a case and a control set, respectively. A derivation that parallels the one for the exposure-only analysis shows that the contribution to the conditional logistic likelihood by a matched pair of pools is:

Hence, both *β* and *γ* and their SEs can be estimated by standard conditional logistic regression tools.

Consider a dichotomous potential effect modifier *W* that is stratum-specific in having the same value for both individuals in the *i*^{th} pair, and suppose that the following model holds:

Here, *γ* denotes the log OR associated with *W* in the absence of exposure and *θ* assesses the change in the log OR for exposure when the level of *W* changes. For this stratum-specific effect modifier, we assemble sets of pairs by partitioning at random within each level of the effect modifier and then separately pooling case specimens and pooling control specimens within each set of pairs. The contribution of each pair of pools to a conditional logistic likelihood is:

(4)

Thus, *β* and *θ* and their SEs are estimated using conditional logistic regression as before and correspond to the parameters for individual-level data. However, *γ* cannot be estimated from either unpooled (*g*=1) or pooled data because, with stratum-specific *W*, the value of *gw* is the same for the case-and the control-pool in each paired pool. This approach also works for a categorical effect modifier or a categorized version of a continuous one.

For a categorical effect modifier W that instead can vary across individuals within a stratum, a modified pooling strategy is needed to assess effect modification. Concordant case-control pairs (where the case and the control have the same value of W) are subject to pooling as described in section 2.2.1 while *W*-discordant case-control pairs are left unpooled. This strategy results in a likelihood contribution that incorporates a term involving subject specific levels of W for the discordant pairs in the exponents of(4), so that parameters β, θ and γ are estimated via conditional logistic regression.

The pooling strategy for a pair-matched study is readily extended to a matched study where each matching stratum contains *m* cases and *n* controls. Here, too, we randomly partition the matched strata into sets of strata. Suppose a set of *g* matched strata have been grouped for pooling. One forms *m* case pools each having *g* case specimens, one specimen sampled at random without replacement from each stratum in the set, and *n* control pools each having *g* control specimens in a similar way (Figure 1). If *n* and *m* have a common divisor, *p*, one could alternatively pool to form *m*/*p* pooling sets for cases and *n*/*p* pooling sets for controls, by including a randomly selected *p* cases (controls) from each of the *g* strata in each pooling set for cases (controls) (Figure 2). In this way each subject (case or control) from a particular stratum contributes to exactly one pooled specimen, and the pooled data retain the *m:n* (or *m*/*p: n*/*p*) matched structure.

Schematic of a pooling strategy for matched case-control studies with a mixed matching strategy. Filled circles represent the cases, empty circles represent the controls, and a line joins the cases and controls in each matched stratum. Boxes surround **...**

Schematic of a pooling strategy for an *m:n* matched case-control study where *m* and *n* have a common divisor. Filled circles represent the cases, empty circles represent the controls, and a line joins the cases and controls in each matched stratum. Boxes **...**

For complex designs where not every stratum contains the same number of cases or of controls(*e.g*., if the matching factor is sibship), a similar pooling strategy will again work, with the proviso that all strata that are assigned to any pooling set must have the same structure, *i.e*., the same number of cases and the same number of controls (Figure 1). For such complex pooling designs, conditional logistic regression can still be employed.

We examined the performance of our approach via simulations. In each study, we simulated 10,000 data sets to compare results from conditional logistic regression based on individual versus pooled exposure measurements. We specified distributions for exposure, covariates and stratum-specific intercept parameters α_{i}; we also specified values for the odds ratio parameters. For each matching stratum, we simulated an α_{i} and any stratum-specific covariates; for each subject within a stratum, we simulated an exposure and any individual covariates. With these values, we determined each subject’s probability of disease through the specified logistic model, and we assigned disease status based on a Bernoulli trial with that disease probability. We retained strata with the desired case-control ratio up to the desired sample size. We then randomly partitioned these matching strata into pooling sets of strata according to the relevant pooling strategy; the pooled exposure value was the average of the individual values. The same simulated data were used for analyses based on individual and on pooled exposures for each simulation.

Our first design used 1:1 matching and comprised 240 case-control pairs (480 subjects, 480 individual assays). We considered pools of size 2, 3, 4, 5 and 6, which would require 240, 160, 120, 96 and 80 assays, respectively, saving as much as 5/6 of the direct assay costs. We generated the stratum-specific intercepts, α_{i}, from a normal distribution with mean -3 and variance 2. We generated log-normal exposures by exponentiating normal random variables with mean 0 and variance 1. We studied three values of *β*:0, 0.08 and −0.08. For this design, results based on pooled exposure were generally comparable to those based on individual exposure measurements in terms of parameter estimate, model-based variance, coverage, power and type I error (Table 1, eTable 1 (http://links.lww.com/)). All scenarios, including analyses based on unpooled data, demonstrated some bias in the estimation of *β* but the bias, as well as the discrepancy between empirical and average model-based variance, increased with the pool size *g*. Regardless of pool size, the model-based variance was slightly smaller than the empirical variance. Nonetheless, the confidence interval coverage was slightly larger than the nominal level of 0.95 for pool sizes up to six. The results were similar for other exposure distributions or when the exposure was associated with the stratum-specific intercept (data not shown).

Results based on 10,000 simulated data sets for estimation and testing of exposure log odds ratio (OR) *β* using a design with 1:1 matching and N=240 strata (pairs).

Using a similar pair-matched design, we also compared the power of pooled analysis with that of unpooled analysis for a fixed number of subjects and alternatively for a fixed number of assays (by including additional individuals) for several values of *β* based on 1000 simulations each for a log-normally distributed exposure. For a fixed sample size of 120 case-control pairs, the power of pooled analysis was comparable with that of the unpooled analysis regardless of pool size (Figure 3A). Though the number of assay determinations went from 240 (unpooled analysis) to 40 (pooled analysis with *g*=6), the power curves were almost indistinguishable. When instead the number of assays was held at 120 pairs, power increased substantially with pool size (Figure 3B). The number of pairs included also increased with pool size from 120 case-control pairs in an unpooled analysis (*g*=1) to 720 pairs for a pooled analysis with *g*=6.

Simulated power curves (averaged over 1000 simulations) for *β* for unpooled and pooled analysis of exposure. (A) Power of unpooled analysis (solid line) and pooled analysis with g = 6 (dashed line) when sample size was fixed at 120 case-control **...**

A second scenario involved more complex structures; we considered a total of 240 matched case-control strata, 120 with 1:1, 90 with 1:2, 30 with 1:3 matching, totaling N=630 individuals. We created pools of size 4, 3, and 2 for the 1:1, 1:2, and 1:3matched strata, respectively. Thus, the pooled analysis needed only 210 assays. The distribution of the exposure and the stratum-specific intercepts were the same as in the first scenario. Results based on pooled exposure assessment were again comparable to results based on individual exposure measurements(Table 2). The pooled analysis produced estimates of *β* that were slightly more biased than those produced by the unpooled analysis. The type I error rate based on a likelihood ratio test of *β* = 0 was higher for the pooled analysis than for the unpooled analysis; however, the confidence interval coverage was close to the nominal 0.95.

Next, we considered a design with 240 case-control pairs that included a binary subject-specific confounder, *W*, having a population prevalence of 0.3. The exposure *U* was log normal, with its log having expectation 0.3*W and variance 1. The stratum-specific intercept, α_{i}, was drawn from a normal distribution with mean -3 and variance 2. The log OR for *W* was *γ* = 0.4 and we varied *β*. Parameter estimates, type I error, power and coverage for both *β* and *γ* based on pooled measurements, especially for pools of size 2 and 3, were comparable to results based on individual measurements(Table 3, eTable 2 (http://links.lww.com/)). The bias again increased with pool size.

Results based on 10,000 simulated data sets for estimation and testing of log OR *β* for a continuous exposure and *g* for a dichotomous confounder using a design with 1:1 matching and N=240 strata(pairs).

We also considered a design with a continuous confounder. We assumed that the log of the exposure (*U*) and the log of the confounder variable (*W*) were bivariate normal with E(log(*U*)) = E(log(*W*)) = 0, Var(log(*U*)) = Var(log(*W*)) = 1 and correlation between log(*U*) and log(*W*) = 0.5. The stratum-specific intercept, α_{i}, was drawn from a normal distribution with mean -3 and variance 2 as before. The log OR for *W* was *γ* = 0.2, and we varied *β*. Parameter estimates, type I error, power and coverage for both *β* and *γ* based on pooled measurements, especially for pools of size 2 and 3, were comparable to results based on individual measurements(eTable 3 (http://links.lww.com/)). The bias again increased with pool size.

We next considered a binary effect modifier *W* (population prevalence 0.3) that was concordant across individuals within each of 960 matched pairs. Exposure *U* had the lognormal distribution with its log having expected value 0.3**W* and variance 1. The stratum-specific intercept, *α*_{i}, had a normal distribution with mean −5 and variance 1. We considered a range of values for *β*, *γ* and *θ*. Similar to ourprevious results, biases in the parameter estimates from pooled analysis for smaller pool sizes (*g* = 2 or 3) were small and comparable to those for unpooled estimates(Table 4 and eTable 4 (http://links.lww.com/) for *g* =0.0; additional data not shown). In general, the estimates of *β* were less biased than were estimates of *θ*. For example, for *β* =−0.2 the average estimate based on the unpooled analysis was −0.201 and the average estimate based on pools of size 6 was −0.207. By contrast, the unpooled estimate of *θ*=−0.3 was −0.312 and the pooled estimate when *g* = 6 was −0.398.

We simulated 480 matched pairs and a binary effect modifier *W* that was not always concordant within pairs. The distribution of *W*, *U* and *α* was the same as in the previous scenarios and we considered a range of values for *β*, *γ*, and *θ*. The results from pooled analysis were again comparable with those based on unpooled analysis (Table 5 and eTable 5 (http://links.lww.com/)for *γ* =0.0; additional data not shown).

Currentlarge-scale studies focus on screening multiple biomarkers to improve risk assessment, prediction and management of disease. Such efforts require assaying stored biospecimens from several thousand subjects to measure levels of numerous biomarkers. Most, if not all, of these biomarkers turn out to be unassociated with the disease,^{16} resulting in loss of bio-resources that may be irreplaceable. In such situations, specimen pooling offers a practical strategy that not only reduces overall assay cost but also conserves specimens for future analyses of additional biomarkers yet to be identified as informative.

A pooling strategy was proposed earlier to estimate the individual-level odds ratio associated with a continuous exposure in unmatched or frequency-matched case-control studies.^{10} We extended that work and showed that unbiased estimation of the individual-level odds ratio parameter can be based on pooled exposure measurements for a fine-matched case-control study. If pooling sets are formed in a way that maintains the matching, a conditional logistic model applies, and OR scan be estimated using standard software. Unlike the method of Weinberg and Umbach,^{10} no offset adjustment is needed. Confounder effects can be estimated similarly and, in the presence of a potential effect modifier, only pairs with concordant values of the effect modifier should be pooled.

Conditional logistic regression involves likelihood-based inference, and the unbiasedness of estimates and the validity of tests and confidence intervals require a large number of observations in the analysis. With small numbers, bias can be severe.^{17} We observed some bias, generally away from the null, which increased as the pool size increased. This bias is attributable to the decreasing number of pooling sets, which reduces the effective sample size. Increasing the number of strata in our simulations by ten-fold eliminated detectable bias (data not shown). Nevertheless, when employing pooled exposure assessment, one should consider this issue and may need to adopt alternative estimators to cope with small numbers.^{17}

Pooled analysis may also be applicable to exposures measured externally in the environment rather than in blood or serum specimens. Environmental exposures such as pesticides, arsenic, or lead can be measured in household dust, tap water, or ambient air. Depending on the medium (dust or water, say) samples from different sources could be combined on a weight or volume basis to form a pooled sample, and exposure assessed in the pooled sample would be used for estimation of odds ratios as outlined here.

The approach we have described might be useful for case-control studies with alternative matching schemes, e.g., randomized recruitment^{18–19} or counter-matching.^{20} In such designs, pools should additionally be stratified by first-stage or screening variables. The implications of pooling in such designs remain to be explored.

Pooling presents both advantages and limitations and may not be the best approach for every study. As mentioned before, when a small fraction of specimens falls under the LOD, then pooling may further reduce this fraction, because a mean of *g* sample values has the same mean but smaller variance than an individual value. For example, if the exposure is distributed as a standard log-normal random variable and the LOD is 0.431, then 20% of the individually-measured exposures fall below the LOD. If 3 random subjects were pooled, then only about 3.4% of the pooled observations would fall below the LOD. In contrast, when a large proportion of specimens fall under the LOD (for example, if the population mean is actually below the LOD for the assay), then pooling can even exacerbate the problem.

Another limitation worth noting is that transformations are difficult to accommodate in a set-based analysis. The argument in the eAppendix (http://links.lww.com) remains correct if, in the underlying logistic model (1), *u* is replaced by some non-linear function of *u* such as log(*u*), *u ^{2}*, or, generically,

Another limitation is that effect-modifiers must be identified and accommodated a priori in the formation of pooling sets. Post-hoc analysis of effect modification between the exposure and another variable would require that the pooling be designed afresh. Continuous effect modifiers, even when known in advance, would require categorization, leading to coarsening and possibly loss of power. Multiple effect modifiers require that pooling be done within strata defined by cross-classified levels of effect modifiers. For example, if both age (young vs. old) and sex (male vs. female) are considered potential effect modifiers, then pooling sets are formed separately within the four age-sex groups. On the other hand, if additional covariates are confounders but not potential effect modifiers, the pooling sets are formed at random, without regard to the age and sex variables, and the value of the confounder for a pool is assigned by summing over values measured on individuals in the pool.

These limitations not withstanding, pooling strategies can greatly reduce the cost of a matched study, both in money and in depletion of irreplaceable specimens, while incurring minimal loss of statistical power or precision.

Funding: Supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (project ES040006-14).

**SDC** Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).

1. NCEH Publication 05-0570. 2005. NCEH Third National Report on human exposure to environmental chemicals.

2. Caudill SP. Characterizing populations of individuals using pooled samples. Journal of Exposure Science and Environmental Epidemiology. 2010;20:29–37. [PubMed]

3. Dorfman R. The detection of defective members of large populations. Annals of Mathematical Statistics. 1943;14:436–440.

4. Emmanuel JC, Bassett M, Smith HJ, Jacobs JA. Pooling of sera for human immunodeficiency virus (HIV) testing -an economical method for use in developing countries. Journal of Clinical Pathology. 1988;41:582–585. [PMC free article] [PubMed]

5. Cunningham R, Northwood JL, Kelly CD, Boxall EH, Andrews NJ. Routine antenatal screening for hepatitis b using pooled sera: validation and review of 10 years experience. Journal of Clinical Pathology. 1998;51:392–395. [PMC free article] [PubMed]

6. Bharti AR, Letendre SL, Patra KP, Vinetz JM, Smith DM. Short report: Malaria diagnosis by a polymerase chain reaction-based assay using a pooling strategy. American Journal of Tropical Medicine and Hygiene. 2009;81:754–757. [PMC free article] [PubMed]

7. Brookmeyer R. Analysis of multistage pooling studies of biological specimens for estimating disease incidence and prevalence. Biometrics. 1999;55:608–612. [PubMed]

8. Liu A, Schisterman EF. Comparison of diagnostic accuracy of biomarkers with pooled assessments. Biometrical Journal. 2003;45:631–644.

9. Sham P, Bader JS, Craig I, O’Donovan M, Owen M. DNA pooling: a tool for large-scale association studies. Nature Reviews Genetics. 2002;3:862–871. [PubMed]

10. Weinberg CR, Umbach DM. Using pooled exposure assessment to improve efficiency in case-control studies. Biometrics. 1999;55:718–726. [PubMed]

11. Breslow NE, Day NE. The analysis of case-control studies. 32. I. IARC Scientific Publications; 1980. Statistical methods in cancer research; pp. 248–279. [PubMed]

12. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3 Lippincott, Williams and Wilkins; Philadelphia, PA: 2008.

13. McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ, Calle EE. Serum 25-hydroxyvitanmin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res. 2009;11(4):R64. [PMC free article] [PubMed]

14. Wang HL, Chen XT, Yang B, Ma FL, Wang S, Tang ML, Hao MG, Ruan DY. Case-control stuffy of blood lead levels and attendtion deficit hyperactivity disorder in Chinese Children. Environ Health Perspectives. 2008;116(10):1401–6. [PMC free article] [PubMed]

15. Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin’s lymphoma: a report from three cohorts. Cancer Res. 2007;67(11):5545–52. [PubMed]

16. Blankenberg S, Zeller T, Saarela O, Havulinna AS, Kee F, Tunstall-Pedoe H, Kuulasmaa K, Yarnell J, Schnabel RB, Wild PS, Münzel TF, Lackner KJ, Tiret L, Evans A, Salomaa V. for the MORGAM Project. Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in2 Population Cohorts. The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM)Biomarker Project. Circulation. 2010;121:2388–2397. [PubMed]

17. Jewell NP. Small-sample bias of point estimators of the odds ratio from matched sets. Biometrics. 1984;40:421–435. [PubMed]

18. Weinberg CR, Wacholder S. The Design and Analysis of Case-Control Studies with Biased Sampling. Biometrics. 1990;46:963–975. [PubMed]

19. Weinberg CR, Sandler DP. Randomized Recruitment in Case-Control Studies. American Journalof Epidemiology. 1991;134(4):421–432. [PubMed]

20. Langholz B, Borgan OR. Counter-matching: A stratified nested case- control sampling method. Biometrika. 1995;82(1):69–79.

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's Canada Institute for Scientific and Technical Information in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers. |